youtube_live
Q3 2026 earnings • released • EPS beat +7.77% • Revenue beat +2.95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
$ 146.98
arrow_downward
-4.21%(-6.45) 1D
11-р сарын 6, 10:48:43 (GMT-5) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$ 141.83
High
$ 147.91
Low
$ 136.42
Mkt. cap
19.67 тэрбум
Avg. vol.
1.86 сая
Volume
1.94 сая
52-wk high
$ 191.01
52-wk low
$ 74.55
EPS
-$ 3.50
Beta
1.67
Shares outstanding
134.20 сая
No. of employees
2 мян
Open
$ 141.83
High
$ 147.91
Low
$ 136.42
Mkt. cap
19.67 тэрбум
Avg. vol.
1.86 сая
Volume
1.94 сая
52-wk high
$ 191.01
52-wk low
$ 74.55
EPS
-$ 3.50
Beta
1.67
Shares outstanding
134.20 сая
No. of employees
2 мян
News stories
From web sources and news partners
Investing.com
·
4 цагийн өмнө
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Yahoo Finance Singapore
·
10 цагийн өмнө
Guardant Health Inc (GH) (Q3 2026) Earnings Call Highlights: Revenue Surges 36% as Shield ...
GenomeWeb
·
13 цагийн өмнө
Guardant Health Q3 Revenue Climbs 36 Percent as Firm Raises Full-Year Guidance
Zacks
·
14 цагийн өмнө
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5 мян
Founded2012
HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com